Indeed, the HSF1 pathway represents an attractive therapeutic target as it not only allows cancer cells to survive aneuploidy-induced proteotoxic stress, but it also plays an important role in cancer progression and chemoresistance [8, 10, 13, 38, 39]. The gene discussed is HSF1; the disease is cancer.